04/01/2021
7:35 PM | Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2021
7:34 PM | Akebia Therapeutics (Issuer)
Spellman David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2021
7:33 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2021
7:33 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2021
7:32 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2021
7:31 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2021
8:07 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2021
6:19 PM | Akebia Therapeutics (Issuer)
Spellman David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2021
6:18 PM | Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2021
6:18 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/18/2021
6:17 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2021
6:17 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2021
6:16 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
4:21 PM | Akebia Therapeutics (Filer)
| Form S-3ASR
| |
02/25/2021
7:04 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2021
7:17 AM | Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
7:15 AM | Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/18/2021
7:03 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2021
5:42 AM | Akebia Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G/A
| |
02/11/2021
11:43 AM | Akebia Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/03/2021
12:33 PM | Akebia Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/28/2021
4:03 PM | Akebia Therapeutics (Issuer)
Cotreau Violetta (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/28/2021
3:29 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2021
3:11 PM | Akebia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/12/2021
6:06 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2020
7:22 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2020
3:17 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/10/2020
8:02 AM | Akebia Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G
| |
11/05/2020
7:15 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2020
1:44 PM | Akebia Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
10/09/2020
2:44 PM | Akebia Therapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
| Form SC 13G/A
| |
09/25/2020
12:00 PM | Akebia Therapeutics (Filer)
| Form CT ORDER
| |
09/25/2020
7:16 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2020
4:00 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2020
3:55 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2020
3:02 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2020
11:54 AM | Akebia Therapeutics (Filer)
| Form CT ORDER
| |
06/18/2020
3:16 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2020
11:02 AM | Akebia Therapeutics (Filer)
| Form CT ORDER
| |
05/21/2020
3:16 PM | Akebia Therapeutics (Filer)
| Form DEFA14A
| |
05/12/2020
3:18 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2020
3:02 PM | Akebia Therapeutics (Filer)
| Form 424B5
| |
05/05/2020
3:12 PM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2020
7:22 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/20/2020
7:58 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2020
8:08 PM | Akebia Therapeutics (Filer)
| Form PRER14A
| |
04/10/2020
3:06 PM | Akebia Therapeutics (Filer)
| Form PRE 14A
| |
04/09/2020
3:11 PM | Akebia Therapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
| Form SC 13G/A
| |
04/08/2020
3:44 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2020
7:31 AM | Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
7:30 AM | Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/07/2020
7:12 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2020
3:58 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2020
3:56 PM | Akebia Therapeutics (Filer)
| Form 424B5
| |
03/10/2020
7:08 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/02/2020
6:29 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
6:28 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
6:27 PM | Akebia Therapeutics (Issuer)
Amello Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
6:26 PM | Akebia Therapeutics (Issuer)
Tubridy Karen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
6:26 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
6:25 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
6:25 PM | Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2020
12:05 PM | Akebia Therapeutics (Filer)
| Form CT ORDER
| |
11/22/2019
5:20 AM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:20 AM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:19 AM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
5:32 AM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
5:31 AM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
4:31 PM | Akebia Therapeutics (Filer)
| Form 424B5
| |
11/12/2019
4:20 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
3:31 PM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2019
7:59 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2019
11:52 AM | Akebia Therapeutics (Filer)
| Form CT ORDER
| |
09/11/2019
3:15 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2019
3:03 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
3:48 PM | Akebia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/08/2019
7:22 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2019
3:04 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2019
3:10 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:03 PM | Akebia Therapeutics (Issuer)
Canute Scott A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:03 PM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2019
3:05 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
6:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
3:07 PM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
3:02 PM | Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2019
7:18 AM | Akebia Therapeutics (Filer)
| Form DEFA14A
| |
05/09/2019
7:16 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
3:05 PM | Akebia Therapeutics (Filer)
| Form DEF 14A
| |
04/18/2019
6:50 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2019
3:01 PM | Akebia Therapeutics (Issuer)
Jain Rita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2019
3:01 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2019
3:00 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
